Trupanion CEO Margaret Tooth sells $25,840 in company stock

Margaret Tooth, CEO and a Director of Trupanion, Inc. (NASDAQ:TRUP), sold 1,000 shares of the company’s common stock on October 9, 2026. The shares were sold at a price of $25.84 per share, resulting in a total transaction value of $25,840. The stock has since risen to $26.57, posting a 7.7% gain over the past week. According to InvestingPro analysis, the stock appears undervalued at current levels, with a PEG ratio of just 0.44 suggesting attractive value relative to growth prospects.

Following this transaction, Ms. Tooth directly holds 184,952 shares of Trupanion common stock. The sale was executed pursuant to a Rule 10b5-1(c) trading plan, which Ms. Tooth adopted on May 11, 2026. This plan was established for financial diversification, and the reporting person did not have discretion regarding the timing of this particular transaction.

In other recent news, Trupanion reported second-quarter 2026 earnings that surpassed expectations, with earnings per share reaching $0.16, compared to the projected $0.1133. The company’s revenue increased by 11% from the previous year, totaling $392.9 million, reflecting continued growth in adjusted operating income and cash flow. Piper Sandler downgraded Trupanion from Overweight to Neutral, citing macroeconomic challenges, and adjusted its price target from $45 to $32. Despite the downgrade, Piper Sandler acknowledged Trupanion’s leading market position and its strong reputation among veterinarians. Meanwhile, Stifel increased its price target for Trupanion to $29 from $28, maintaining a Hold rating. This adjustment followed Trupanion’s decision to end its relationship with Pets Best, its largest Other customer, by the end of the third quarter of 2028, which is expected to lead to a decline in enrollment. These developments highlight various factors influencing Trupanion’s current market standing and future prospects.